| Company/Division name | Abbott Laboratories |
| Parent company | Abbott Laboratories |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2025 |
| Capital investment ($): | 250 |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | medical devices |
| What non-domestic negative factors made offshoring less attractive? | Tariffs |
| What domestic positive factors made reshoring more attractive? | Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |
